Duke Kannapolis News

The Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk) project will build on a successful pilot study completed by Duke Ortho and CTSI in August. Like the pilot, recruitment for the BACk study will take place in Durham and Kannapolis, where CTSI operates the Duke Kannapolis research site on the North Carolina Research Campus. 

Analysis of a COVID-19 research study based at CTSI’s Duke Kannapolis site found that education level, household income, and baseline intention were associated with longer times to vaccination, and the most common reasons for not being vaccinated were safety concerns, side effects, and vaccine effectiveness.

Duke CTSI is proud to announce the appointment of Kanecia Zimmerman, MD, PhD, MPH, and Joe McClernon, PhD as faculty associate directors of the CTSI. Zimmerman will serve as the associate director of Engagement and Health Translation, and McClernon will serve as the associate director of Partnerships and Integration.

The Duke Clinical and Translational Science Institute (CTSI) is pleased to announce the launch of the Center for Precision Health (CPH), a collaboration that will harness the power of genomic, biomarker, and health data to transform patient care and population health.

Samples and data from the MURDOCK Study helped Duke University researchers identify new indicators of fracture risk among older adults with type 2 diabetes.

Using samples and data from the MURDOCK Study, Duke University researchers have found more evidence linking the disruption of a key metabolic pathway with the development of Alzheimer’s disease.

The ease and speed of obtaining samples and data from a groundbreaking community-based biorepository at Duke Kannapolis helped to accelerate a recent heart failure discovery by Duke researchers.

Mary E. Klotman, MD, dean of the Duke University School of Medicine, announced today that Susanna Naggie, MD, MHS, has been named director of the Duke Clinical and Translational Science Institute (CTSI), effective immediately.

Svati H. Shah, MD, MHS, director of CTSI's research site at Duke Kannapolis, has been awarded a Distinguished Professorship.

The Duke Clinical and Translational Science Institute (CTSI) is collaborating with Duke Emergency Medicine on a public health surveillance project dubbed Preventing Emerging Infections Through Vaccine Effectiveness Testing, or PREVENT II. Anyone who works at a Duke Health location and has recently been tested for COVID-19, whether positive or negative for infection, may be eligible to participate.